181 related articles for article (PubMed ID: 19120366)
21. [Expression of nm23 genes in acute myeloid leukemia and its clinical significance].
Meng QX; Jiang R; Yang BQ; Zhang HY; Liu J; Pang LP; Wang J
Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):369-71. PubMed ID: 12941193
[TBL] [Abstract][Full Text] [Related]
22. Identification of novel molecular prognostic markers for paediatric T-cell acute lymphoblastic leukaemia.
Gottardo NG; Hoffmann K; Beesley AH; Freitas JR; Firth MJ; Perera KU; de Klerk NH; Baker DL; Kees UR
Br J Haematol; 2007 May; 137(4):319-28. PubMed ID: 17456054
[TBL] [Abstract][Full Text] [Related]
23. Acute leukemia: subtype discovery and prediction of outcome by gene expression profiling.
Downing JR
Verh Dtsch Ges Pathol; 2003; 87():66-71. PubMed ID: 16888896
[TBL] [Abstract][Full Text] [Related]
24. Leukaemia cases in Central Hospital, Riyadh (Saudi Arabia).
Khan MQ; Shivarudrappa AS; el-Bialy S; al-Khawagi MZ; al-Mofarreh M
J Indian Med Assoc; 1991 Feb; 89(2):38-42. PubMed ID: 2056174
[TBL] [Abstract][Full Text] [Related]
25. Gene expression with prognostic implications in cytogenetically normal acute myeloid leukemia.
Baldus CD; Bullinger L
Semin Oncol; 2008 Aug; 35(4):356-64. PubMed ID: 18692686
[TBL] [Abstract][Full Text] [Related]
26. High expression of EVI1 and MEL1 is a compelling poor prognostic marker of pediatric AML.
Jo A; Mitani S; Shiba N; Hayashi Y; Hara Y; Takahashi H; Tsukimoto I; Tawa A; Horibe K; Tomizawa D; Taga T; Adachi S; Yoshida T; Ichikawa H
Leukemia; 2015 May; 29(5):1076-83. PubMed ID: 25567132
[TBL] [Abstract][Full Text] [Related]
27. P-glycoprotein and multidrug resistance associated protein-1 activity in 132 acute myeloid leukemias according to FAB subtypes and cytogenetics risk groups.
Legrand O; Zompi S; Perrot JY; Faussat AM; Benderra Z; Chaoui D; Marie JP
Haematologica; 2004 Jan; 89(1):34-41. PubMed ID: 14754604
[TBL] [Abstract][Full Text] [Related]
28. Correlation between expression of CD56/NCAM and severe leukostasis in hyperleukocytic acute myelomonocytic leukaemia.
Novotny JR; Nückel H; Dührsen U
Eur J Haematol; 2006 Apr; 76(4):299-308. PubMed ID: 16519701
[TBL] [Abstract][Full Text] [Related]
29. Detection of the CBFB/MYH11 fusion gene in de novo acute myeloid leukemia (AML): a single-institution study of 224 Japanese AML patients.
Monma F; Nishii K; Shiga J; Sugahara H; Lorenzo F; Watanabe Y; Kawakami K; Hosokai N; Yamamori S; Katayama N; Shiku H
Leuk Res; 2007 Apr; 31(4):471-6. PubMed ID: 17052753
[TBL] [Abstract][Full Text] [Related]
30. Translocation (6;17)(q23;q11.2): a novel cytogenetic abnormality in congenital acute myeloid leukemia?
Ferguson EC; Talley P; Vora A
Cancer Genet Cytogenet; 2005 Nov; 163(1):71-3. PubMed ID: 16271959
[TBL] [Abstract][Full Text] [Related]
31. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.
Koh Y; Park J; Ahn KS; Kim I; Bang SM; Lee JH; Yoon SS; Soon Lee D; Yiul Lee Y; Park S; Kim BK
Ann Hematol; 2009 Nov; 88(11):1089-97. PubMed ID: 19296110
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetic and molecular analysis of MLL rearrangements in acute lymphoblastic leukaemia survivors.
Brassesco MS; Montaldi AP; Gras DE; Camparoto ML; Martinez-Rossi NM; Scrideli CA; Tone LG; Sakamoto-Hojo ET
Mutagenesis; 2009 Mar; 24(2):153-60. PubMed ID: 19028982
[TBL] [Abstract][Full Text] [Related]
33. Current status of gene expression profiling in the diagnosis and management of acute leukaemia.
Bacher U; Kohlmann A; Haferlach T
Br J Haematol; 2009 Jun; 145(5):555-68. PubMed ID: 19344393
[TBL] [Abstract][Full Text] [Related]
34. Association of MLL amplification with poor outcome in acute myeloid leukemia.
Maitta RW; Cannizzaro LA; Ramesh KH
Cancer Genet Cytogenet; 2009 Jul; 192(1):40-3. PubMed ID: 19480936
[TBL] [Abstract][Full Text] [Related]
35. Banding and molecular cytogenetic studies detected a CBFB-MYH11 fusion gene that appeared as abnormal chromosomes 1 and 16 in a baby with acute myeloid leukemia FAB M4-Eo.
Macedo Silva ML; Raimondi SC; Abdelhay E; Gross M; Mkrtchyan H; de Figueiredo AF; Ribeiro RC; de Jesus Marques-Salles T; Sobral ES; Gerardin Land MP; Liehr T
Cancer Genet Cytogenet; 2008 Apr; 182(1):56-60. PubMed ID: 18328953
[TBL] [Abstract][Full Text] [Related]
36. Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis.
Inaba H; Fan Y; Pounds S; Geiger TL; Rubnitz JE; Ribeiro RC; Pui CH; Razzouk BI
Cancer; 2008 Aug; 113(3):522-9. PubMed ID: 18484648
[TBL] [Abstract][Full Text] [Related]
37. Prediction of relapse in paediatric pre-B acute lymphoblastic leukaemia using a three-gene risk index.
Hoffmann K; Firth MJ; Beesley AH; Freitas JR; Ford J; Senanayake S; de Klerk NH; Baker DL; Kees UR
Br J Haematol; 2008 Mar; 140(6):656-64. PubMed ID: 18302714
[TBL] [Abstract][Full Text] [Related]
38. Hsp27: a novel therapeutic target for pediatric M4/M5 acute myeloid leukemia.
Yang L; Cao L; Yang M; Tang D; Kang R; Min X; Zhu S; Yu Y
Oncol Rep; 2013 Apr; 29(4):1459-66. PubMed ID: 23404246
[TBL] [Abstract][Full Text] [Related]
39. A three-year prospective study of 137 cases of acute leukaemia in Zimbabwe.
Paul B; Mukiibi JM; Mandisodza A; Levy L; Nkrumah FK
Cent Afr J Med; 1992 Mar; 38(3):95-9. PubMed ID: 1516127
[TBL] [Abstract][Full Text] [Related]
40. Frequency of fab subtypes in acute myeloid leukemia patients at Aga Khan University Hospital Karachi.
Harani MS; Adil SN; Shaikh MU; Kakepoto GN; Khurshid M
J Ayub Med Coll Abbottabad; 2005; 17(1):26-9. PubMed ID: 15929522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
